Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Musculoskeletal | Rheumatology | Family Medicine
Clinical Trials: Osteoporosis
A listing of clinical trials currently looking for volunteers to enroll in Osteoporosis studies. Click on the closest city to find more detailed information on a research study in your area.
Alabama
Birmingham : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Arizona
Paradise Valley : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Scottsdale : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Tucson : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study That Will Compare the Effect of Two Drugs on Patients With Low Bone Mass and a Recent Hip Fracture
Tucson : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
California
Anaheim : Anaheim Clinical Trials (ACT)
Are you concerned about Osteoporosis?
Stanford : Stanford University School of Medicine
A Randomized Clinical Trial of High-Impact Low Frequency Exercise to Improve Biomarkers of Bone Turnover Among Low Weight Patients With Eating Disorders.
Walnut Creek : Diablo Clinical Research
Could you have thinning bones or osteoporosis?
Walnut Creek : Diablo Clinical Research
Do You Have Osteoporosis?
View More »
Anaheim : Novartis Investigative Site
Safety and Efficacy of Multiple Dosing Regimens of BPS804 in Postmenopausal Women With Low Bone Mineral Density
Downey : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Fresno : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Greenbrae : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Laguna Hills : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study That Will Compare the Effect of Two Drugs on Patients With Low Bone Mass and a Recent Hip Fracture
Laguna Hills : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Lancaster : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Murrieta : Research Site
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Sacramento : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
San Diego : Research Site
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
San Francisco : UCSF Imaging Center
Assessment of Bone Micro-Architecture Using HR-pQCT
San Luis Obispo : Research Site
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Santa Monica : Research Site
Safety and Efficacy Study to Evaluate Denosumab Compared With Zoledronic Acid in Postmenopausal Women With Osteoporosis
Walnut Creek : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Walnut Creek : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Walnut Creek : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Colorado
Denver : Research Site
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Lakewood :
Phase 2 Study of BA058 Transdermal Delivery in Postmenopausal Women With Osteoporosis
Lakewood : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Lakewood : Research Site
Safety and Efficacy Study to Evaluate Denosumab Compared With Zoledronic Acid in Postmenopausal Women With Osteoporosis
Lakewood : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
View More »
Lakewood :
Study to Evaluate the Safety and Efficacy of BA058 for Prevention of Fracture in Postmenopausal Women
Lakewood : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Longmont : Research Site
Safety and Efficacy Study to Evaluate Denosumab Compared With Zoledronic Acid in Postmenopausal Women With Osteoporosis
Connecticut
Middlebury : Research Site
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
New Britain : Research Site
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Florida
Boca Raton : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Fort Lauderdale : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study That Will Compare the Effect of Two Drugs on Patients With Low Bone Mass and a Recent Hip Fracture
Jacksonville : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study That Will Compare the Effect of Two Drugs on Patients With Low Bone Mass and a Recent Hip Fracture
Leesburg : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Miami : Novartis Investigative Site
Safety and Efficacy of Multiple Dosing Regimens of BPS804 in Postmenopausal Women With Low Bone Mineral Density
View More »
Miami :
Study to Evaluate the Safety and Efficacy of BA058 for Prevention of Fracture in Postmenopausal Women
N. Miami :
Study to Evaluate the Safety and Efficacy of BA058 for Prevention of Fracture in Postmenopausal Women
Palm Harbor : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Stuart : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Tampa : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Tampa :
Study to Evaluate the Safety and Efficacy of BA058 for Prevention of Fracture in Postmenopausal Women
Trinity : Research Site
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
West Palm Beach : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Georgia
Idaho
Coeur d'Alene : Research Site
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Illinois
Indiana
Iowa
West Des Moines : Research Site
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Kansas
Louisiana
New Orleans : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Shreveport : Research Site
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Shreveport : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Maryland
Annapolis : Research Site
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Baltimore : Research Site
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Bethesda :
Phase 2 Study of BA058 Transdermal Delivery in Postmenopausal Women With Osteoporosis
Bethesda : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Bethesda : Research Site
Safety and Efficacy Study to Evaluate Denosumab Compared With Zoledronic Acid in Postmenopausal Women With Osteoporosis
View More »
Bethesda : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Bethesda :
Study to Evaluate the Safety and Efficacy of BA058 for Prevention of Fracture in Postmenopausal Women
Bethesda : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Greenbelt : Research Site
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Hagerstown : Research Site
Safety and Efficacy Study to Evaluate Denosumab Compared With Zoledronic Acid in Postmenopausal Women With Osteoporosis
Massachusetts
Boston : Massachusetts General Hospital
Testosterone and Alendronate in Hypogonadal Men
Boston : Massachusetts General Hospital
The Role of Parathyroid Hormone (PTH) in Low Bone Mass in Anorexia Nervosa
Michigan
Detroit : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Detroit : Research Site
Safety and Efficacy Study to Evaluate Denosumab Compared With Zoledronic Acid in Postmenopausal Women With Osteoporosis
Detroit : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Minnesota
Missouri
St Louis : Research Site
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
St. Louis : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Nebraska
New Jersey
Berlin : Research Site
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Berlin : Novartis Investigative Site
Safety and Efficacy of Multiple Dosing Regimens of BPS804 in Postmenopausal Women With Low Bone Mineral Density
Clifton : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Englewood : Research Site
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Mount Laurel : Research Site
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
New Mexico
New York
Garden City : Research Site
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Lake Success : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
New York : Research Site
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Syracuse : Research Site
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
North Carolina
North Dakota
Ohio
Pennsylvania
Bala Cynwyd : Research Site
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Duncansville : Research Site
Effects of Denosumab on the Pharmacokinetics of Etanercept
Duncansville : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Duncansville : Novartis Investigative Site
Safety and Efficacy of Multiple Dosing Regimens of BPS804 in Postmenopausal Women With Low Bone Mineral Density
Duncansville : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
View More »
Lancaster : Research Site
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Philadelphia : Research Site
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Pittsburgh : University of Pittsburgh, Osteoporosis Prevention & Treatment Center
Fracture (FX) Improvement With Teriparatide: FiX-IT Study
Pittsburgh : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Pittsburgh : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Tennessee
Texas
Dallas : Metroplex Clinical Research Center
Do You Have Rheumatoid Arthritis? Osteoporosis or Osteopenia? Research Study 20101324
San Antonio : ICON Development Solutions
Recruiting postmenopausal females with risk factors for or a diagnosis of osteoporosis, ages of 45-75, for a clinical research study.
View More »
Dallas : Research Site
Effects of Denosumab on the Pharmacokinetics of Etanercept
Dallas : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Denton : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Houston : Research Site
Safety and Efficacy Study to Evaluate Denosumab Compared With Zoledronic Acid in Postmenopausal Women With Osteoporosis
San Antonio : Research Site
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Virginia
Richmond : Research Site
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Richmond : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Salem : Research Site
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Wisconsin
Madison : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Argentina
Australia
Box Hill : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Darlinghurst : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Footscray : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Geelong : Research Site
Safety and Efficacy Study to Evaluate Denosumab Compared With Zoledronic Acid in Postmenopausal Women With Osteoporosis
Geelong : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
View More »
Heidelberg West : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Heidelberg West : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Herston : Research Site
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Herston : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Keswick : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Kogarah : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Nedlands : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Parkville : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Randwick : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Ringwood East : Research Site
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
St Leonards : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Wahroonga : Research Site
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Westmead : Novartis Investigative Site
1 Year Open-label Extension to CZOL446H2337 Safety and Efficacy Trial of Zoledronic Acid Twice Yearly in Osteoporotic Children Treated With Glucocorticoids for Chronic Inflammatory Conditions
Westmead : Novartis Investigative Site
An Efficacy and Safety Trial of Intravenous Zoledronic Acid Twice Yearly in Osteoporotic Children Treated With Glucocorticoids for Chronic Inflammatory Conditions
Austria
Graz : Research Site
Observational Study of Prolia® in Postmenopausal Women With Osteoporosis
Graz : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Hohenems : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Klagenfurt : Research Site
Observational Study of Prolia® in Postmenopausal Women With Osteoporosis
Landeck : Research Site
Observational Study of Prolia® in Postmenopausal Women With Osteoporosis
View More »
Leibnitz : Research Site
Observational Study of Prolia® in Postmenopausal Women With Osteoporosis
Linz : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Linz : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Salzburg : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study That Will Compare the Effect of Two Drugs on Patients With Low Bone Mass and a Recent Hip Fracture
Salzburg : Research Site
Observational Study of Prolia® in Postmenopausal Women With Osteoporosis
Sankt Stefan : Research Site
Observational Study of Prolia® in Postmenopausal Women With Osteoporosis
Vienna : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Voecklabruck : Research Site
Observational Study of Prolia® in Postmenopausal Women With Osteoporosis
Voitsberg : Research Site
Observational Study of Prolia® in Postmenopausal Women With Osteoporosis
Wien : Research Site
Observational Study of Prolia® in Postmenopausal Women With Osteoporosis
Wien : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Belgium
Aalst : O.L. Vrouwziekenhuis
OsseoScrew Versus Fenestrated Pedicle Screws Augmented With Polymethylmethacrylate
Brussels : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Bruxelles : ULB Hopital Erasme
OsseoScrew Versus Fenestrated Pedicle Screws Augmented With Polymethylmethacrylate
Bruxelles : CHIREC parc Leopold
OsseoScrew Versus Fenestrated Pedicle Screws Augmented With Polymethylmethacrylate
Bruxelles : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
View More »
Genk : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Genk : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Gent : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Gent : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Gent : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Gilly : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Laken : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Leuven : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Leuven : Research Site
Safety and Efficacy Study to Evaluate Denosumab Compared With Zoledronic Acid in Postmenopausal Women With Osteoporosis
Leuven : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Leuven : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Liège : Research Site
Safety and Efficacy Study to Evaluate Denosumab Compared With Zoledronic Acid in Postmenopausal Women With Osteoporosis
Liège : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Liege : CHC St. Joseph
OsseoScrew Versus Fenestrated Pedicle Screws Augmented With Polymethylmethacrylate
Liège : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Liege 1 : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Merksem : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Mons : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Yvoir : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Yvoir : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Brazil
Brasilia :
Study to Evaluate the Safety and Efficacy of BA058 for Prevention of Fracture in Postmenopausal Women
Curitiba :
Study to Evaluate the Safety and Efficacy of BA058 for Prevention of Fracture in Postmenopausal Women
Rio de Janeiro :
Study to Evaluate the Safety and Efficacy of BA058 for Prevention of Fracture in Postmenopausal Women
Sao Paolo :
Study to Evaluate the Safety and Efficacy of BA058 for Prevention of Fracture in Postmenopausal Women
São Paulo : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
View More »
Vitoria :
Study to Evaluate the Safety and Efficacy of BA058 for Prevention of Fracture in Postmenopausal Women
Bulgaria
Plovdiv : Research Site
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Sofia : Research Site
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Canada
Barrie : Research Site
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Brampton : Research Site
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Brantford : Research Site
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Burlington : Research Site
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Calgary : Novartis Investigative Site
An Efficacy and Safety Trial of Intravenous Zoledronic Acid Twice Yearly in Osteoporotic Children Treated With Glucocorticoids for Chronic Inflammatory Conditions
View More »
Calgary : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Calgary : Research Site
Safety and Efficacy Study to Evaluate Denosumab Compared With Zoledronic Acid in Postmenopausal Women With Osteoporosis
Edmonton : Novartis Investigative Site
An Efficacy and Safety Trial of Intravenous Zoledronic Acid Twice Yearly in Osteoporotic Children Treated With Glucocorticoids for Chronic Inflammatory Conditions
Halifax : Research Site
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Halifax : Novartis Investigative Site
An Efficacy and Safety Trial of Intravenous Zoledronic Acid Twice Yearly in Osteoporotic Children Treated With Glucocorticoids for Chronic Inflammatory Conditions
Halifax : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Hamilton : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Kelowna : Research Site
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Kelowna : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Kitchener : Research Site
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Laval : Research Site
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
London : Research Site
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Montreal : Novartis Investigative Site
1 Year Open-label Extension to CZOL446H2337 Safety and Efficacy Trial of Zoledronic Acid Twice Yearly in Osteoporotic Children Treated With Glucocorticoids for Chronic Inflammatory Conditions
Montreal : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study That Will Compare the Effect of Two Drugs on Patients With Low Bone Mass and a Recent Hip Fracture
Montreal : Research Site
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Montreal : Novartis Investigative Site
An Efficacy and Safety Trial of Intravenous Zoledronic Acid Twice Yearly in Osteoporotic Children Treated With Glucocorticoids for Chronic Inflammatory Conditions
Montreal : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Montreal : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Montreal : Mcgill University Health center
The Study of the Early Administration of Alendronate on Prevention of Bone Loss After Hip Fracture.
Oakville : Research Site
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Oakville : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Ottawa : Novartis Investigative Site
1 Year Open-label Extension to CZOL446H2337 Safety and Efficacy Trial of Zoledronic Acid Twice Yearly in Osteoporotic Children Treated With Glucocorticoids for Chronic Inflammatory Conditions
Ottawa : Novartis Investigative Site
An Efficacy and Safety Trial of Intravenous Zoledronic Acid Twice Yearly in Osteoporotic Children Treated With Glucocorticoids for Chronic Inflammatory Conditions
Quebec : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Quebec : Research Site
Safety and Efficacy Study to Evaluate Denosumab Compared With Zoledronic Acid in Postmenopausal Women With Osteoporosis
Quebec : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Sainte-Foy : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Saskatoon : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Sherbrooke : Centre hospitalier universitaire de Sherbrooke
Strategies to Treat Osteoporosis Following a Fragility Fracture
St. John : Novartis Investigative Site
An Efficacy and Safety Trial of Intravenous Zoledronic Acid Twice Yearly in Osteoporotic Children Treated With Glucocorticoids for Chronic Inflammatory Conditions
Toronto : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study That Will Compare the Effect of Two Drugs on Patients With Low Bone Mass and a Recent Hip Fracture
Toronto : Research Site
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Toronto : Research Site
Safety and Efficacy Study to Evaluate Denosumab Compared With Zoledronic Acid in Postmenopausal Women With Osteoporosis
Toronto : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Toronto : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Trois-Rivieres : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Trois-Rivieres : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Vancouver : Novartis Investigative Site
1 Year Open-label Extension to CZOL446H2337 Safety and Efficacy Trial of Zoledronic Acid Twice Yearly in Osteoporotic Children Treated With Glucocorticoids for Chronic Inflammatory Conditions
Vancouver : Novartis Investigative Site
An Efficacy and Safety Trial of Intravenous Zoledronic Acid Twice Yearly in Osteoporotic Children Treated With Glucocorticoids for Chronic Inflammatory Conditions
Vancouver : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Vancouver : Research Site
Safety and Efficacy Study to Evaluate Denosumab Compared With Zoledronic Acid in Postmenopausal Women With Osteoporosis
Vancouver : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Vancouver : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Victoria : Research Site
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Victoria : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Westmout : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Winnipeg : Novartis Investigative Site
An Efficacy and Safety Trial of Intravenous Zoledronic Acid Twice Yearly in Osteoporotic Children Treated With Glucocorticoids for Chronic Inflammatory Conditions
Winnipeg : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Croatia
Czech Republic
Benesov : Research Site
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Brno : Research Site
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Brno : Research Site
Prospective Observational Study to Describe Characteristics and Management of Patients Treated With Prolia® in Routine Clinical Practice
Brno : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Brno : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
View More »
Brno :
Study to Evaluate the Safety and Efficacy of BA058 for Prevention of Fracture in Postmenopausal Women
Ceske Budejovice : Research Site
Prospective Observational Study to Describe Characteristics and Management of Patients Treated With Prolia® in Routine Clinical Practice
Ceske Budejovice : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Ceske Budejovice : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Havlickuv Brod : Research Site
Prospective Observational Study to Describe Characteristics and Management of Patients Treated With Prolia® in Routine Clinical Practice
Havlickuv Brod : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Hradec Kralove : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Jindrichuv Hradec : Research Site
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Karlovy Vary : Research Site
Prospective Observational Study to Describe Characteristics and Management of Patients Treated With Prolia® in Routine Clinical Practice
Klatovy : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study That Will Compare the Effect of Two Drugs on Patients With Low Bone Mass and a Recent Hip Fracture
Klatovy : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Klatovy : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Klatovy : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Kromeriz : Research Site
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Kutna Hora : Research Site
Prospective Observational Study to Describe Characteristics and Management of Patients Treated With Prolia® in Routine Clinical Practice
Novy Jicin : Research Site
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Olomouc : Research Site
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Ostrava : Research Site
Prospective Observational Study to Describe Characteristics and Management of Patients Treated With Prolia® in Routine Clinical Practice
Ostrava-Trebovice : Research Site
Prospective Observational Study to Describe Characteristics and Management of Patients Treated With Prolia® in Routine Clinical Practice
Ostrava-Trebovice : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Ostrava-Trebovice : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Pardubice : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Pardubice : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Pardubice :
Study to Evaluate the Safety and Efficacy of BA058 for Prevention of Fracture in Postmenopausal Women
Plzen : Research Site
Prospective Observational Study to Describe Characteristics and Management of Patients Treated With Prolia® in Routine Clinical Practice
Plzen : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Plzen : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Prague : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study That Will Compare the Effect of Two Drugs on Patients With Low Bone Mass and a Recent Hip Fracture
Prague :
Study to Evaluate the Safety and Efficacy of BA058 for Prevention of Fracture in Postmenopausal Women
Prague : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Praha 11 : Research Site
Prospective Observational Study to Describe Characteristics and Management of Patients Treated With Prolia® in Routine Clinical Practice
Praha 11 : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Praha 2 : Research Site
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Praha 2 : Research Site
Prospective Observational Study to Describe Characteristics and Management of Patients Treated With Prolia® in Routine Clinical Practice
Praha 2 : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Praha 2 : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Praha 3 : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Praha 3 : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Praha 4 : Research Site
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Praha 4 - Nusle : Research Site
Prospective Observational Study to Describe Characteristics and Management of Patients Treated With Prolia® in Routine Clinical Practice
Praha 6 : Research Site
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Trutnov : Research Site
Prospective Observational Study to Describe Characteristics and Management of Patients Treated With Prolia® in Routine Clinical Practice
Uherske Hradiste : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Uherske Hradiste : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Usti nad Labem : Research Site
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Vsetin : Research Site
Prospective Observational Study to Describe Characteristics and Management of Patients Treated With Prolia® in Routine Clinical Practice
Zlin : Research Site
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Zlin : Osteocentrum Zlin
Prospective Observational Study to Describe Characteristics and Management of Patients Treated With Prolia® in Routine Clinical Practice
Zlin : Research Site
Prospective Observational Study to Describe Characteristics and Management of Patients Treated With Prolia® in Routine Clinical Practice
Zlin : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Zlin : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Denmark
Ã…rhus C : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Ã…rhus C : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Aalborg :
Phase 2 Study of BA058 Transdermal Delivery in Postmenopausal Women With Osteoporosis
Aalborg : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Aalborg : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
View More »
Aalborg :
Study to Evaluate the Safety and Efficacy of BA058 for Prevention of Fracture in Postmenopausal Women
Aarhus : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study That Will Compare the Effect of Two Drugs on Patients With Low Bone Mass and a Recent Hip Fracture
Ballerup :
Phase 2 Study of BA058 Transdermal Delivery in Postmenopausal Women With Osteoporosis
Ballerup : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Ballerup : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Ballerup :
Study to Evaluate the Safety and Efficacy of BA058 for Prevention of Fracture in Postmenopausal Women
Glostrup : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Glostrup : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Hvidovre : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Hvidovre : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Odense : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study That Will Compare the Effect of Two Drugs on Patients With Low Bone Mass and a Recent Hip Fracture
Odense : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Odense : Department of Endocrinology
Study of Male Osteoporosis and Aging
Odense : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Vejie :
Phase 2 Study of BA058 Transdermal Delivery in Postmenopausal Women With Osteoporosis
Vejle : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Vejle : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Vejle :
Study to Evaluate the Safety and Efficacy of BA058 for Prevention of Fracture in Postmenopausal Women
Viborg : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study That Will Compare the Effect of Two Drugs on Patients With Low Bone Mass and a Recent Hip Fracture
Estonia
Pärnu : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Tallinn :
Phase 2 Study of BA058 Transdermal Delivery in Postmenopausal Women With Osteoporosis
Tallinn : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Tallinn : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Tallinn :
Study to Evaluate the Safety and Efficacy of BA058 for Prevention of Fracture in Postmenopausal Women
View More »
Tartu : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Tartu : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Tartu :
Study to Evaluate the Safety and Efficacy of BA058 for Prevention of Fracture in Postmenopausal Women
Finland
Helsinki : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Jyväskylä : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Kuopio : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study That Will Compare the Effect of Two Drugs on Patients With Low Bone Mass and a Recent Hip Fracture
Oulu : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study That Will Compare the Effect of Two Drugs on Patients With Low Bone Mass and a Recent Hip Fracture
Turku : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study That Will Compare the Effect of Two Drugs on Patients With Low Bone Mass and a Recent Hip Fracture
View More »
Turku : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
France
Angers : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study That Will Compare the Effect of Two Drugs on Patients With Low Bone Mass and a Recent Hip Fracture
Caen : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
La Crau : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
La Roche Sur Yon : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study That Will Compare the Effect of Two Drugs on Patients With Low Bone Mass and a Recent Hip Fracture
Lyon : Research Site
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
View More »
Lyon : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Lyon : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Orléans Cedex : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Orleans : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study That Will Compare the Effect of Two Drugs on Patients With Low Bone Mass and a Recent Hip Fracture
Orleans : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Paris : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study That Will Compare the Effect of Two Drugs on Patients With Low Bone Mass and a Recent Hip Fracture
Paris : Cochin hospital
Effects of Proteins Fraction Derived From Milk on Osteoporosis Prevention
Paris Cedex 5 : Research Site
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Saint-Etienne : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study That Will Compare the Effect of Two Drugs on Patients With Low Bone Mass and a Recent Hip Fracture
Saint-Etienne : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Toulouse : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study That Will Compare the Effect of Two Drugs on Patients With Low Bone Mass and a Recent Hip Fracture
Toulouse : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Vandoeuvre les Nancy : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Germany
Aachen : Research Site
Observational Study of Prolia® in Postmenopausal Women With Osteoporosis
Augsburg : Research Site
Observational Study of Prolia® in Postmenopausal Women With Osteoporosis
Bad Kreuznach : Research Site
Observational Study of Prolia® in Postmenopausal Women With Osteoporosis
Bad Reichenhall : Research Site
Observational Study of Prolia® in Postmenopausal Women With Osteoporosis
Bammental : Research Site
Observational Study of Prolia® in Postmenopausal Women With Osteoporosis
View More »
Bautzen : Research Site
Observational Study of Prolia® in Postmenopausal Women With Osteoporosis
Berlin : Research Site
Observational Study of Prolia® in Postmenopausal Women With Osteoporosis
Berlin (Hellersdorf) : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Cottbus : Research Site
Observational Study of Prolia® in Postmenopausal Women With Osteoporosis
Düsseldorf : Research Site
Observational Study of Prolia® in Postmenopausal Women With Osteoporosis
Dresden : Research Site
Observational Study of Prolia® in Postmenopausal Women With Osteoporosis
Dresden : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Erfurt : Research Site
Observational Study of Prolia® in Postmenopausal Women With Osteoporosis
Essen : Department of Internal Medicine III, Alfried Krupp Krankenhaus Essen Steele
Comparison of the Effect of an Ongoing Treatment With Alendronate or a Drug Holiday on the Fracture Risk in Osteoporotic Patients With Bisphosphonate Long Term Therapy
Frankfurt : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Frankfurt : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Freiburg : Research Site
Observational Study of Prolia® in Postmenopausal Women With Osteoporosis
Freudenstadt : Research Site
Observational Study of Prolia® in Postmenopausal Women With Osteoporosis
Friedrichroda : Research Site
Observational Study of Prolia® in Postmenopausal Women With Osteoporosis
Hamburg : Research Site
Observational Study of Prolia® in Postmenopausal Women With Osteoporosis
Hamburg : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Hannover : Research Site
Observational Study of Prolia® in Postmenopausal Women With Osteoporosis
Hannover : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Hattingen : Research Site
Observational Study of Prolia® in Postmenopausal Women With Osteoporosis
Heinsberg : Research Site
Observational Study of Prolia® in Postmenopausal Women With Osteoporosis
Hettstedt : Research Site
Observational Study of Prolia® in Postmenopausal Women With Osteoporosis
Hildesheim : Research Site
Observational Study of Prolia® in Postmenopausal Women With Osteoporosis
Immenstadt : Research Site
Observational Study of Prolia® in Postmenopausal Women With Osteoporosis
Koblenz : Katholische Klinikum Marienhof
OsseoScrew Versus Fenestrated Pedicle Screws Augmented With Polymethylmethacrylate
Lahnstein : Research Site
Observational Study of Prolia® in Postmenopausal Women With Osteoporosis
Leipzig : Research Site
Observational Study of Prolia® in Postmenopausal Women With Osteoporosis
Leipzig : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Leipzig : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Leverkusen : Research Site
Observational Study of Prolia® in Postmenopausal Women With Osteoporosis
Mönchengladbach-Rheydt : Research Site
Observational Study of Prolia® in Postmenopausal Women With Osteoporosis
Müllheim : Research Site
Observational Study of Prolia® in Postmenopausal Women With Osteoporosis
München : Research Site
Observational Study of Prolia® in Postmenopausal Women With Osteoporosis
Magdeburg : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Magdeburg : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Mainz : UNIVERSITÄTSMEDIZIN der Johannes-Gutenberg Universität Mainz
OsseoScrew Versus Fenestrated Pedicle Screws Augmented With Polymethylmethacrylate
Marburg : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study That Will Compare the Effect of Two Drugs on Patients With Low Bone Mass and a Recent Hip Fracture
Marburg : Research Site
Observational Study of Prolia® in Postmenopausal Women With Osteoporosis
Marburg : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Muenchen : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Nürnbrecht : Research Site
Observational Study of Prolia® in Postmenopausal Women With Osteoporosis
Neustadt : Research Site
Observational Study of Prolia® in Postmenopausal Women With Osteoporosis
Nienburg : Research Site
Observational Study of Prolia® in Postmenopausal Women With Osteoporosis
Osnabrück : Research Site
Observational Study of Prolia® in Postmenopausal Women With Osteoporosis
Potsdam : Research Site
Observational Study of Prolia® in Postmenopausal Women With Osteoporosis
Saarbrücken : Research Site
Observational Study of Prolia® in Postmenopausal Women With Osteoporosis
Stockach : Research Site
Observational Study of Prolia® in Postmenopausal Women With Osteoporosis
Ulm : Research Site
Observational Study of Prolia® in Postmenopausal Women With Osteoporosis
Völklingen : Research Site
Observational Study of Prolia® in Postmenopausal Women With Osteoporosis
Würzburg : Research Site
Observational Study of Prolia® in Postmenopausal Women With Osteoporosis
Würzburg : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Wadgassen : Research Site
Observational Study of Prolia® in Postmenopausal Women With Osteoporosis
Wittstock : Research Site
Observational Study of Prolia® in Postmenopausal Women With Osteoporosis
Zerbst : Research Site
Observational Study of Prolia® in Postmenopausal Women With Osteoporosis
Greece
Alexandroupoli : Research Site
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Athens : Research Site
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Athens : Research Site
Observational Study of Prolia® in Postmenopausal Women With Osteoporosis
Athens : Iaso Hospital of Athens, Center of Endocrinology and Bone Metabolism
Osteoporosis Screening Trial
Athens : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
View More »
Athens : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Chania, Crete : Research Site
Observational Study of Prolia® in Postmenopausal Women With Osteoporosis
Heraklion : Research Site
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Heraklion : Research Site
Observational Study of Prolia® in Postmenopausal Women With Osteoporosis
Heraklion, Crete : Research Site
Observational Study of Prolia® in Postmenopausal Women With Osteoporosis
Kifissia : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study That Will Compare the Effect of Two Drugs on Patients With Low Bone Mass and a Recent Hip Fracture
Kifissia : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Larissa : Research Site
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Larissa : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Levadia : Research Site
Observational Study of Prolia® in Postmenopausal Women With Osteoporosis
Patra : Research Site
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Patra : Research Site
Observational Study of Prolia® in Postmenopausal Women With Osteoporosis
Patras : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Thessaloniki : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study That Will Compare the Effect of Two Drugs on Patients With Low Bone Mass and a Recent Hip Fracture
Thessaloniki : Research Site
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Thessaloniki : Research Site
Observational Study of Prolia® in Postmenopausal Women With Osteoporosis
Thessaloniki : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Thessaloniki : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Hong Kong
Hong Kong :
Study to Evaluate the Safety and Efficacy of BA058 for Prevention of Fracture in Postmenopausal Women
Hungary
Baja : Research Site
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Bekescsaba : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Budapest : Research Site
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Budapest : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Budapest : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
View More »
Budapest : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Debrecen : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Debrecen : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Debrecen : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Eger : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Gyor : Research Site
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Gyor : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Kaposvar : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Nyiregyhaza : Research Site
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Szeged : Research Site
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Szeged : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Szeged : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Veszprem : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Zalaegerszeg : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
India
Ahmedabad : Research Site
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Aurangabad : Research Site
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Bangalore : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Chennai : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Jaipur : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
View More »
Ludhiana : Research Site
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Madurai : Research Site
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Mumbai : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Nashik : Research Site
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Pune : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Vellore : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Ireland
Italy
Arenzano GE : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Cagliari : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study That Will Compare the Effect of Two Drugs on Patients With Low Bone Mass and a Recent Hip Fracture
Firenze : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study That Will Compare the Effect of Two Drugs on Patients With Low Bone Mass and a Recent Hip Fracture
Firenze : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Firenze : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
View More »
Milano : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study That Will Compare the Effect of Two Drugs on Patients With Low Bone Mass and a Recent Hip Fracture
Nervi : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Novara : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Padova : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Palermo : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study That Will Compare the Effect of Two Drugs on Patients With Low Bone Mass and a Recent Hip Fracture
Roma : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Rome : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study That Will Compare the Effect of Two Drugs on Patients With Low Bone Mass and a Recent Hip Fracture
Rome : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Rozzano : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Siena : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Torino : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Torino : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Valeggio Sul Mincio : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Verona : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Japan
Atugi-shi : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Bungo-Ono :
Study of AK156 in Primary Osteoporosis Patients
Bungoono-shi : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Chiba :
Study of AK156 in Primary Osteoporosis Patients
Chiisagata-gun : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
View More »
Fujimi-shi : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Fukui-shi : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Fukuoka :
Clinical Study of AK159 in Healthy Postmenopausal Women
Fukuoka :
Study of AK156 in Primary Osteoporosis Patients
Fukuoka-shi : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Fukutsu-shi : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Hachioji-shi : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Inami-cho :
Study of AK156 in Primary Osteoporosis Patients
Kagoshima :
Study of AK156 in Primary Osteoporosis Patients
Kikukawa :
Study of AK156 in Primary Osteoporosis Patients
Kitakyushu-shi : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Kiyose-shi : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Kofu-shi : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Kumamoto :
Study of AK156 in Primary Osteoporosis Patients
Kure :
Study of AK156 in Primary Osteoporosis Patients
Kurume-shi : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Many Locations :
Julina Post-marketing Surveillance for Postmenopausal Osteoporosis in Japan
Many Locations : Updated
Wellnara Post-marketing Surveillance in Japan
Matsumoto :
Study of AK156 in Primary Osteoporosis Patients
Matsumoto-shi : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Minamikyusyu-shi : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Minato-ku : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Miyazaki :
Study of AK156 in Primary Osteoporosis Patients
Morioka :
Study of AK156 in Primary Osteoporosis Patients
Morioka-shi : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Ota-ku : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Oyama :
Study of AK156 in Primary Osteoporosis Patients
Sagamihara-shi : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Saga-shi : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Sapporo :
Study of AK156 in Primary Osteoporosis Patients
Sendai :
Study of AK156 in Primary Osteoporosis Patients
Sendai-shi : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Setagaya :
Study of AK156 in Primary Osteoporosis Patients
Shinagawa :
Study of AK156 in Primary Osteoporosis Patients
Shinagawa-ku : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Suginami-ku : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Takamatsu-shi : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Tokorozawa :
Study of AK156 in Primary Osteoporosis Patients
Tonami :
Study of AK156 in Primary Osteoporosis Patients
Toride-shi : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Tosu :
Study of AK156 in Primary Osteoporosis Patients
Ueda-shi : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Urayasu-shi : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Yokohama :
Study of AK156 in Primary Osteoporosis Patients
Yokohama-shi : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Korea, Republic of
Many Locations :
Angeliq Regulatory Post Marketing Surveillance
Seoul : GSK Investigational Site
BONVIVA(Ibandronate) Injection PMS(Post-marketing Surveillance)
Seoul : The Catholic University of Korea Seoul St. Mary's Hospital
Phase III Clinical Trial of DP-R206 and Bonvia In Postmenopausal Women With Osteoporosis
Suwon : Ajou University Hospital
Pharmacokinetics of Maxmarvil® in Healthy Postmenopausal Women
Latvia
Jelgava : Research Site
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Liepaja : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Liepaja : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Riga : Research Site
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Riga : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
View More »
Riga : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Lithuania
Kaunas : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Klaipeda : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Vilnius : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Vilnius : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Vilnius :
Study to Evaluate the Safety and Efficacy of BA058 for Prevention of Fracture in Postmenopausal Women
Malaysia
Kuala Lumpur : Hospital of UKM, National University of Malaysia
Effects of Hesperidin on Bone Biomarkers in Postmenopausal Women
Mexico
Netherlands
Leiden : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Venlo : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
New Zealand
Christchurch : Research Site
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Christchurch : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Christchurch : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Grafton, Auckland : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Takapuna, North Shore City : Research Site
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
View More »
Tauranga : Research Site
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Whangarei : Research Site
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Norway
Elverum : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Oslo : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study That Will Compare the Effect of Two Drugs on Patients With Low Bone Mass and a Recent Hip Fracture
Oslo : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Stavanger : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Poland
Bialystok : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Bialystok : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Bialystok :
Study to Evaluate the Safety and Efficacy of BA058 for Prevention of Fracture in Postmenopausal Women
Bialystok : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Elblag : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
View More »
Gdansk : Research Site
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Gdynia : Research Site
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Gdynia : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Gdynia : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Gliwice : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Gliwice : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Katowice : Research Site
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Katowice : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Katowice : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Katowice :
Study to Evaluate the Safety and Efficacy of BA058 for Prevention of Fracture in Postmenopausal Women
Kielce :
Study to Evaluate the Safety and Efficacy of BA058 for Prevention of Fracture in Postmenopausal Women
Kraków : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Kraków : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Krakow : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Krakow : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Lodz :
Phase 2 Study of BA058 Transdermal Delivery in Postmenopausal Women With Osteoporosis
Lodz : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Lodz : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Lodz :
Study to Evaluate the Safety and Efficacy of BA058 for Prevention of Fracture in Postmenopausal Women
Lublin : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Myslowice : Research Site
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Opole : Research Site
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Poznan : Research Site
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Poznan : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Poznan : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Slupsk : Research Site
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Swidnik : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Szczecin : Research Site
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
ToruÅ" : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Warsaw :
Phase 2 Study of BA058 Transdermal Delivery in Postmenopausal Women With Osteoporosis
Warsaw : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Warszaw :
Study to Evaluate the Safety and Efficacy of BA058 for Prevention of Fracture in Postmenopausal Women
Warszawa : Research Site
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Warszawa : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Warszawa : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Wroclaw : Research Site
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Wroclaw : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Wroclaw : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Zgierz :
Study to Evaluate the Safety and Efficacy of BA058 for Prevention of Fracture in Postmenopausal Women
Puerto Rico
Hato Rey : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Rio Piedras : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
San Juan : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study That Will Compare the Effect of Two Drugs on Patients With Low Bone Mass and a Recent Hip Fracture
San Juan : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Romania
Bucharest : Novartis Investigative Site
An Efficacy and Safety Trial of Intravenous Zoledronic Acid Twice Yearly in Osteoporotic Children Treated With Glucocorticoids for Chronic Inflammatory Conditions
Bucharest : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Bucharest : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Bucharest :
Study to Evaluate the Safety and Efficacy of BA058 for Prevention of Fracture in Postmenopausal Women
Bucuresti : Novartis Investigative Site
An Efficacy and Safety Trial of Intravenous Zoledronic Acid Twice Yearly in Osteoporotic Children Treated With Glucocorticoids for Chronic Inflammatory Conditions
View More »
Iasi : Site Reference ID/Investigator# 53862
Evaluation of the Role of Adalimumab on Extraarticular Manifestation - Bone Metabolism and Bone Mineral Density in Patients With Active Rheumatoid Arthritis
Targu-Mures : Site Reference ID/Investigator# 53865
Evaluation of the Role of Adalimumab on Extraarticular Manifestation - Bone Metabolism and Bone Mineral Density in Patients With Active Rheumatoid Arthritis
Russian Federation
Ekaterinburg : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Ivanovo : Research Site
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Moscow : Research Site
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Moscow : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Nizhny Novgorod : Research Site
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
View More »
Rostov-na-Dony : Research Site
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Yaroslavl : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Slovakia
Banska Bystrica : Research Site
Prospective Observational Study to Describe Characteristics and Management of Patients Treated With Prolia® in Routine Clinical Practice
Bratislava : Research Site
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Bratislava : Research Site
Prospective Observational Study to Describe Characteristics and Management of Patients Treated With Prolia® in Routine Clinical Practice
Humenne : Research Site
Prospective Observational Study to Describe Characteristics and Management of Patients Treated With Prolia® in Routine Clinical Practice
Kosice : Research Site
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
View More »
Kosice : Research Site
Prospective Observational Study to Describe Characteristics and Management of Patients Treated With Prolia® in Routine Clinical Practice
Kosice-Saca : Research Site
Prospective Observational Study to Describe Characteristics and Management of Patients Treated With Prolia® in Routine Clinical Practice
Lubochna : Research Site
Prospective Observational Study to Describe Characteristics and Management of Patients Treated With Prolia® in Routine Clinical Practice
Lucenec : Research Site
Prospective Observational Study to Describe Characteristics and Management of Patients Treated With Prolia® in Routine Clinical Practice
Martin : Research Site
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Martin : Research Site
Prospective Observational Study to Describe Characteristics and Management of Patients Treated With Prolia® in Routine Clinical Practice
Nitra : Research Site
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Nitra : Research Site
Prospective Observational Study to Describe Characteristics and Management of Patients Treated With Prolia® in Routine Clinical Practice
Presov : Research Site
Prospective Observational Study to Describe Characteristics and Management of Patients Treated With Prolia® in Routine Clinical Practice
Trnava : Research Site
Prospective Observational Study to Describe Characteristics and Management of Patients Treated With Prolia® in Routine Clinical Practice
Zilina : Research Site
Prospective Observational Study to Describe Characteristics and Management of Patients Treated With Prolia® in Routine Clinical Practice
Slovenia
Celje : Research Site
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Ljubljana : Research Site
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Slovenj Gradec : Research Site
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
South Africa
George : Research Site
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Kempton Park : Research Site
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Paarl : Research Site
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Port Elizabeth : Research Site
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Pretoria : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
View More »
Tygerberg : Research Site
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Spain
Alcira : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Barcelona : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study That Will Compare the Effect of Two Drugs on Patients With Low Bone Mass and a Recent Hip Fracture
Barcelona : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Barcelona : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Barcelona : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
View More »
Cadiz : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Girona : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study That Will Compare the Effect of Two Drugs on Patients With Low Bone Mass and a Recent Hip Fracture
Granada : Research Site
Safety and Efficacy Study to Evaluate Denosumab Compared With Zoledronic Acid in Postmenopausal Women With Osteoporosis
Granada : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Leon : Hospital de Leon
OsseoScrew Versus Fenestrated Pedicle Screws Augmented With Polymethylmethacrylate
Madrid : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study That Will Compare the Effect of Two Drugs on Patients With Low Bone Mass and a Recent Hip Fracture
Madrid : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Madrid : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Madrid : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Marbella : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study That Will Compare the Effect of Two Drugs on Patients With Low Bone Mass and a Recent Hip Fracture
Pozuelo de Alarcón : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Sabadell : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Sant Joan DespÃ- : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Santander : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Sevilla : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study That Will Compare the Effect of Two Drugs on Patients With Low Bone Mass and a Recent Hip Fracture
Sevilla : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Valencia : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Valencia : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Sweden
Linköping : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Mölndal : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Malmo : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study That Will Compare the Effect of Two Drugs on Patients With Low Bone Mass and a Recent Hip Fracture
Mölndal : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study That Will Compare the Effect of Two Drugs on Patients With Low Bone Mass and a Recent Hip Fracture
Stockholm : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study That Will Compare the Effect of Two Drugs on Patients With Low Bone Mass and a Recent Hip Fracture
View More »
Stockholm : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Umeå : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Switzerland
Bern : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Fribourg : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Geneva 14 : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Lausanne : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Zurich : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
United Kingdom
Birmingham : Novartis Investigative Site
An Efficacy and Safety Trial of Intravenous Zoledronic Acid Twice Yearly in Osteoporotic Children Treated With Glucocorticoids for Chronic Inflammatory Conditions
Birmingham : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Birmingham : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Cambridge : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Cardiff : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
View More »
Cardiff : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Chorley : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Chorley : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Glasgow : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Glasgow : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Liverpool : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Liverpool : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Manchester : Novartis Investigative Site
An Efficacy and Safety Trial of Intravenous Zoledronic Acid Twice Yearly in Osteoporotic Children Treated With Glucocorticoids for Chronic Inflammatory Conditions
Manchester : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Manchester : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Northwood : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Nottingham : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study That Will Compare the Effect of Two Drugs on Patients With Low Bone Mass and a Recent Hip Fracture
Reading : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Reading : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Sheffield : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
